))
Healthy Conversations brings health care experts together with CVS Health leaders for open discussions via video and podcast on timely topics like COVID-19 and insight into both the challenges facing the frontlines and the emerging innovations that will ultimately transform the industry.
Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Manage episode 266653556 series 2740117
By MasterMedFacts LLC, Dr RR Baliga, MD, and MBA. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343
Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion238 episodes
